Buscar
15/10/2024
Structural heart transcatheter interventions in orthotopic cardiac transplant and left ventricular assist devices recipients: A nationwide study
Blasco-Turrión, S, Crespo-Leiro, MG, Trenado, VD, Hion, PL, Molina, BD, Roura, G, Alvarez-Osorio, MP, Gómez-bueno, M, Bautista, CO, Diaz, JF, Bravo, IPG, Moreno, R, Sarnago-Cebada, F, González, NS, Hernandez, JM, del Blanco, BG, Farrero, M, Nadal, RO, Martin, P, de la Fuente, L, Sanz-Sánchez, J, Pérez, SM, Fernández, VA, Hospital, JAG, Granados, AL, Couto-Mallon, D, Espinosa, M, Sousa, DR, Zatarain-Nicolás, E, Aizpurua, DA, Vilella, RL, Roman, JAS, Amat-Santos, IJ. Structural heart transcatheter interventions in orthotopic cardiac transplant and left ventricular assist devices recipients: A nationwide study. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2024; 413DOI:10.1016/j.ijcard.2024.132340. PMID:38992809. IF:3.200(Q2/3D).
01/10/2024
Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial
Freixa, X, Cruz-Gonzalez, I, Cepas-Guillen, P, Millan, X, Antunez-Muinos, P, Flores-Umanzor, E, Asmarats, L, Regueiro, A, Lopez-Tejero, S, Li, CHP, Sanchis, L, Rodes-Cabau, J, Arzamendi, D. Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial. JAMA Cardiology. 2024; 9(10)DOI:10.1001/jamacardio.2024.2335. PMID:39110427. IF:14.100(Q1/1D).
01/10/2024
Efficacy and safety of hypertonic saline therapy in ambulatory patients with heart failure: The SALT-HF trial
Marcos, MC, de la Espriella, R, Comín-Colet, J, Zegrí-Reiriz, I, Gracia, JR, Morales-Rull, JL, Llàcer, P, Díez-Villanueva, P, Jiménez-Marrero, S, Bagudá, JD, Cortés, CO, Restrepo-Córdoba, MA, Goirigolzarri-Artaza, J, García-Pinilla, JM, Barrios, E, Díaz, SD, Hernández, EM, Sanchez-Marteles, M, Núñez, J. Efficacy and safety of hypertonic saline therapy in ambulatory patients with heart failure: The SALT-HF trial. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26(10)DOI:10.1002/ejhf.3390. PMID:39056478. IF:10.800(Q1/1D).
01/10/2024
APOLO: Phase II Trial of Induction ChemoImmunotherapy Plus Chemoradiotherapy and Maintenance Immunotherapy in Stage III NSCLC
Provencio, M, Campos, B, Guirado, M, Vilà, L, Campelo, MRG, Dorta, M, Estévez, SV, Ferrandez, A, Sala, MA, Ortega, AL, Blasco, A, Insa, A, Areses, MC, Sullivan, I, Castro, RL, Calvo, V, Rodríguez -Abreu, D, Bosch-Barrera, J, López-Martín, A, Marsé, R, Torrado, L, Matskov, K, Giner, J, Bruno, MF, Saugar, ES, Martínez-Toledo, C, Cruz-Bermudez, A. APOLO: Phase II Trial of Induction ChemoImmunotherapy Plus Chemoradiotherapy and Maintenance Immunotherapy in Stage III NSCLC. Journal of Thoracic Oncology. 2024; 19(10)DOI:. PMID:. IF:20.800(Q1/1D).
24/09/2024
Recovery of Left Ventricular Function and Long-Term Outcomes in Patients With Takotsubo
Almendro-Delia, M, López-Flores, L, Uribarri, A, Vedia, O, Blanco-Ponce, E, López-Flores, MD, Rivas-García, AP, Fernández-Cordón, C, Sionis, A, Martín-García, AC, Vazirani, R, Corbí-Pascual, M, Salamanca, J, Pérez-Castellanos, A, Martínez, M, Becerra, VM, Aritza-Conty, D, López-País, J, Guillén-Marzo, M, Lluch-Requerey, C, García-Rubira, JC, Núñez-Gil, IJ. Recovery of Left Ventricular Function and Long-Term Outcomes in Patients With Takotsubo. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2024; 84(13)DOI:10.1016/j.jacc.2024.05.075. PMID:39293882. IF:22.300(Q1/1D).
28/08/2024
Left ventricular outflow tract obstruction in Takotsubo syndrome with cardiogenic shock: prognosis and treatment
Vila-Sanjuán, S, Nuñez-Gil, IJ, Vedia, O, Corbi-Pascual, M, Salamanca, J, Martinez-Selles, M, Blanco, E, Almendro-Delia, M, Pérez-Castellanos, A, Martin-Garcia, AC, Tomasino, M, Vazirani, R, Fernández-Cordón, C, Cambra, AD, Becerra-Muñoz, VM, Guillén, M, Reyes, JA, Uribarri, A. Left ventricular outflow tract obstruction in Takotsubo syndrome with cardiogenic shock: prognosis and treatment. HEART. 2024; 110(23)DOI:10.1136/heartjnl-2024-324205. PMID:39209437. IF:4.400(Q1/3D).
12/08/2024
Long-Term Results of Bioresorbable Vascular Scaffolds in Patients With In-Stent Restenosis The RIBS VI Study
Cuesta, J, Pérez-Vizcayno, MJ, del Blanco, BG, Bosa, F, de Prado, AP, Rumoroso, JR, Romaguera, R, Gutiérrez, H, Touchard, AG, López-Minguez, JR, Trillo, R, Hernandez, JMD, Moreno, R, Velázquez, M, Moris, C, Kockar, MJ, Jiménez-Quevedo, P, Bastante, T, del Val, D, Rivero, F, Alfonso, F. Long-Term Results of Bioresorbable Vascular Scaffolds in Patients With In-Stent Restenosis The RIBS VI Study. JACC-Cardiovascular Interventions. 2024; 17(15)DOI:10.1016/j.jcin.2024.05.038. PMID:39142758. IF:11.400(Q1/1D).
12/08/2024
Position Statement on Cardiac Computed Tomography Following Left Atrial Appendage Occlusion
Korsholm, K, Iriart, X, Saw, J, Wang, DD, Berti, S, Galea, R, Freixa, X, Arzamendi, D, De Backer, O, Kramer, A, Cademartiri, F, Cochet, H, Odenstedt, J, Aminian, A, Raeber, L, Cruz-Gonzalez, I, Garot, P, Jensen, JM, Alkhouli, M, Nielsen-Kudsk, JE. Position Statement on Cardiac Computed Tomography Following Left Atrial Appendage Occlusion. JACC-Cardiovascular Interventions. 2024; 17(15)DOI:10.1016/j.jcin.2024.04.050. PMID:39142755. IF:11.400(Q1/1D).